Rotating injection locations between the abdomen, thigh, and upper arm prevents any single area from becoming sensitized
There is no confirmed causal link between retatrutide and pancreatitis at this stage, but vigilance is warranted given the drug's pharmacological class
Some researchers believe retatrutides glucagon activity may contribute to additional effects on fat metabolism and energy expenditure compared to dual agonist therapies
The GCGR arm adds pathways tirzepatide lacks: hepatic fatty-acid oxidation (~85–90% liver fat reduction in Phase 2a MASLD), adipose lipolysis, and thermogenic energy expenditure
In the body, it still works through GLP-1 receptor activation, reducing hunger signals, slowing gastric emptying and improving metabolic function, adds John
The Bottom Line is that you dont necessarily have to choose